Evidence map›Paper›PMID 32374589›Full record

ArticleBiomacromolecules2020

Optical Control of Cytokine Signaling via Bioinspired, Polymer-Induced Latency.

Lacey A Perdue, Priscilla Do, Camille David, Andrew Chyong, Anna V Kellner, Amanda Ruggieri, Hye Ryong Kim, Khalid Salaita, Gregory B Lesinski, Christopher C Porter and 1 more

Open access · greenAbstract read
In one paragraph

Article in Biomacromolecules, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.5field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Lacey A PerdueCoulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, Georgia 30332-0002, United States.
Priscilla DoCoulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, Georgia 30332-0002, United States.
Camille DavidDepartment of Pediatrics, Emory School of Medicine, Atlanta, Georgia 30322, United States.
Andrew ChyongCoulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, Georgia 30332-0002, United States.
Anna V KellnerCoulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, Georgia 30332-0002, United States.
Amanda RuggieriDepartment of Hematology and Medical Oncology, Emory School of Medicine, Atlanta, Georgia 30322, United States.
Hye Ryong KimCoulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, Georgia 30332-0002, United States.
Khalid SalaitaCoulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, Georgia 30332-0002, United States.ORCID 0000-0003-4138-3477
Gregory B LesinskiDepartment of Hematology and Medical Oncology, Emory School of Medicine, Atlanta, Georgia 30322, United States.
Christopher C PorterDepartment of Pediatrics, Emory School of Medicine, Atlanta, Georgia 30322, United States.
Erik C DreadenCoulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, Georgia 30332-0002, United States.ORCID 0000-0002-4954-8443
Georgia Institute of Technology · USEmory University · US

Funding

T32 Research Training Program in ImmunoEngineeringT32EB021962 · NIBIB · GEORGIA INSTITUTE OF TECHNOLOGY · PI JULIA E BABENSEE · 2017 to 2026
$1.9M
DNA mechanotechnology to investigate the role of PD1 biophysics in T cell signalingF31CA243502 · NCI · EMORY UNIVERSITY · PI KELLNER, ANNA · 2020 to 2022
$138k
NCI NIH HHS F31 CA243502NIBIB NIH HHS T32 EB021962
6 · The paper itself

Abstract

Cytokine signaling is challenging to study and therapeutically exploit as the effects of these proteins are often pleiotropic. A subset of cytokines can, however, achieve signal specificity via association with latency-inducing proteins, which cage the cytokine until disrupted by discreet biological stimuli. Inspired by this precision, here, we describe a strategy for synthetic induction of cytokine latency via modification with photolabile polymers that mimic latency while attached then restore protein activity in response to light, thus controlling the magnitude, duration, and location of cytokine signals. We characterize the high dynamic range of cytokine activity modulation and find that polymer-induced latency, alone, can prolong in vivo circulation and bias receptor subunit binding. We further show that protein derepression can be achieved with a near single-cell resolution and demonstrate the feasibility of transcutaneous photoactivation. Future extensions of this approach could enable multicolor, optical reprogramming of cytokine signaling networks and more precise immunotherapies.

Indexed as

PolymersSignal TransductionCytokinesProtein BindingProtein TransportCytokinesPolymers

Identifiers

PMID32374589
PMCPMC8496955
OpenAlexW3023310452

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.